Artrya (ASX:AYA) Net Margin % : -57,238.46% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Artrya Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Artrya's Net Income for the six months ended in Dec. 2024 was A$-7.44 Mil. Artrya's Revenue for the six months ended in Dec. 2024 was A$0.01 Mil. Therefore, Artrya's net margin for the quarter that ended in Dec. 2024 was -57,238.46%.

The historical rank and industry rank for Artrya's Net Margin % or its related term are showing as below:

ASX:AYA' s Net Margin % Range Over the Past 10 Years
Min: -112015.39 Med: 0 Max: 0
Current: -112015.39

ASX:AYA's Net Margin % is ranked worse than
100% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 2.005 vs ASX:AYA: -112015.39

Artrya Net Margin % Historical Data

The historical data trend for Artrya's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Net Margin % Chart

Artrya Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Net Margin %

Artrya Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Margin %	Get a 7-Day Free Trial			-	-	-	-	-57,238.46

Competitive Comparison of Artrya's Net Margin %

For the Health Information Services subindustry, Artrya's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artrya's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Artrya's Net Margin % distribution charts can be found below:

* The bar in red indicates where Artrya's Net Margin % falls into.

Save Embed

;

Save Embed

;

Artrya Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Artrya's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-14	/	0
	=	%

Artrya's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-7.441	/	0.013
	=	-57,238.46 %

Artrya (ASX:AYA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Artrya Net Margin % Related Terms

Thank you for viewing the detailed overview of Artrya's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Artrya Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1257 Hay Street, West Perth, Perth, WA, AUS, 6005

Website

https://www.artrya.com

Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines